Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current trends in luminescence-based assessment of apoptosis.
Moldovan C, Onaciu A, Toma V, Munteanu RA, Gulei D, Moldovan AI, Stiufiuc GF, Feder RI, Cenariu D, Iuga CA, Stiufiuc RI. Moldovan C, et al. Among authors: moldovan ai. RSC Adv. 2023 Oct 30;13(45):31641-31658. doi: 10.1039/d3ra05809c. eCollection 2023 Oct 26. RSC Adv. 2023. PMID: 37908656 Free PMC article. Review.
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression.
Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, Moldovan A, Moldovan C, Florea A, Pasca S, Pop LA, Moisoiu V, Budisan L, Pop-Bica C, Ciocan C, Buiga R, Muresan MS, Stiufiuc R, Ionescu C, Berindan-Neagoe I. Gulei D, et al. Cell Death Dis. 2018 Jan 19;9(2):66. doi: 10.1038/s41419-017-0102-8. Cell Death Dis. 2018. PMID: 29352232 Free PMC article.
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.
Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, Deak D, Desmirean M, Trifa A, Fetica B, Gafencu G, Selicean S, Moisoiu V, Micu WT, Berce C, Sacu A, Moldovan A, Colita A, Bumbea H, Tanase A, Dascalescu A, Zdrenghea M, Stiufiuc R, Leopold N, Tetean R, Burzo E, Tomuleasa C, Berindan-Neagoe I. Jurj A, et al. Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515. doi: 10.1080/10408363.2018.1499707. Epub 2018 Sep 21. Crit Rev Clin Lab Sci. 2018. PMID: 30238808 Review.
Gold nanorods: from anisotropy to opportunity. An evolution update.
Onaciu A, Braicu C, Zimta AA, Moldovan A, Stiufiuc R, Buse M, Ciocan C, Buduru S, Berindan-Neagoe I. Onaciu A, et al. Nanomedicine (Lond). 2019 May;14(9):1203-1226. doi: 10.2217/nnm-2018-0409. Epub 2019 May 10. Nanomedicine (Lond). 2019. PMID: 31075049 Review.
New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells.
Ciocan-Cartita CA, Jurj A, Zanoaga O, Cojocneanu R, Pop LA, Moldovan A, Moldovan C, Zimta AA, Raduly L, Pop-Bica C, Buse M, Budisan L, Virag P, Irimie A, Gomes Dias SM, Berindan-Neagoe I, Braicu C. Ciocan-Cartita CA, et al. J Exp Clin Cancer Res. 2020 Nov 13;39(1):241. doi: 10.1186/s13046-020-01736-2. J Exp Clin Cancer Res. 2020. PMID: 33187552 Free PMC article.
22 results